Genmab — November 2016
-
Actelion har vist en dygtig CEO
-
ACTELION HAS GIVEN J&J ACCESS TO SOME OF ITS FINANCIAL INFORMATION AS PART OF THE DEAL NEGOTIATIONS - BLOOMBERG, CITING SOURCES - Reuters News
-
JNJ har forhøjet buddet med 16%
-
rettelse, actelion er gået op med 16% pga højere bud
-
-
ja det er en hård CEO de har
-
han har jo også hele tiden sagt, at intet er til salg
-
YES
-
og de ejer begge to masser af aktier
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
